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sity aswell as theeffectofparentalACEon factors contributing
to child resilience, such as parenting style and attachment. If
these associationsprove tobepredictive, screening for paren-
tal ACE in pediatric practice would allow for early interven-
tion to increase family resiliency and minimize risk for cur-
rent child adversity.
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Association Between Long Telomere Length
and Insulin Sensitization in Adolescent Girls
With Hyperinsulinemic Androgen Excess
The centile of telomere length from early adulthood until
senescence is mainly set between early gestation and
adolescence.1Hyperinsulinemicandrogenexcess (HIAE) is the
most prevalent endocrinopathy of adolescent girls and is fre-
quently driven by an absolute or relative excess of fat.2 Hy-
perinsulinemic androgen excess in adolescence is associated
with a higher risk for a broad range of endocrine, metabolic,
and cardiovascular complications later in life.3
Hyperinsulinemic androgenexcess is traditionally treated
withanoral contraceptive (OC;evenwhencontraception isnot
an issue) that silences the ovarian androgen production, gen-
erates a pharmacological rise of circulating sex hormone–
binding globulin, and leads to a condition of hyperestrogenic
anovulation with regular pseudomenses.2,3
Early andprolonged insulin sensitizationmaybecome an
alternative treatmentbecause it cannot only attenuate the an-
drogen excess (asOCsdo) but also has anti-aging effects, such
as lowering total, abdominal, visceral, and hepatic adiposity,
attenuating low-grade inflammation, reducing intima-media
thickness, and normalizing ovulatory function and men-
strual regularity.2 The latter benefits may require the addi-
tion of an intrauterine device for contraceptive purposes.
Differential telomere lengthening might allow insulin-
sensitizing interventions toexertmore long-termbenefits com-
pared with OCs in adolescent girls with HIAE.
Methods | We measured leukocyte telomere length (LTL) by
quantitativepolymerase chain reaction innonobese girlswith
HIAEwho participated in a first randomized trial (OC vs insu-
lin sensitization; ISRCTN45546616) across 24 months (18
months receiving treatment and6monthsnot receiving treat-
ment; Figure). This study was approved by the institutional
review board of the Hospital Sant Joan de Deu, University of
Barcelona, Spain. Participantsprovidedwritten informedcon-
sent. The compared interventions were ethinyl estradiol cy-
proteroneacetatevsa low-dosecombinationof7.5mg/dofpio-
glitazone, 62.5mg/dof flutamide, and850mg/dofmetformin
(PioFluMet).4
Figure. Leukocyte Telomere Length and Insulin Sensitization
in Adolescent GirlsWith Hyperinsulinemic Androgen Excess
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Longitudinal results of leukocyte telomere length (by telomere repeat copy
number to the single gene copy number [T/S] ratio) in adolescent girls with
hyperinsulinemic androgen excess whowere randomized to receive either an
oral contraceptive (ethinyl estradiol cyproterone acetate [EE-CA]; N = 14) or an
insulin-sensitizing treatment (N = 16) of low-dose pioglitazone (7.5 mg/d),
flutamide (62.5 mg/d), andmetformin (850mg/d) (PioFluMet) between 0 and
18months and who received no treatment between 18 and 24months. The
upper limit of the gray zone corresponds to a Z score of +2 in healthy control
girls (mean [SE] age, 16.4 [0.4] years, mean [SE] bodymass index [calculated as
weight in kilograms divided by height in meters squared], 22.1 [0.2]; N = 18).
Results in treatment groups indicate a slow on-treatment divergence followed
by the rapid posttreatment convergence of telomere lengths.
a P = .01.
bP = .003 for differences between groups in changes from start (by 2-sided t
test).
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Results |TheLTL (expressed in the telomere repeat copynum-
ber to the single gene copy number ratio) remained un-
changed during and after the OC intake. In contrast, the LTL
doubled while taking PioFluMet and returned to baseline af-
ter thePioFluMet intakewasstopped(Figure).TheLTLchanges
across treatment groupsduring 18months related inversely to
fasting insulinemia, body fat fractionbydual energy x-ray ab-
sorptiometry, and visceral and hepatic adiposity bymagnetic
resonance imaging (all rvalueswerebetween−0.53 and−0.57;
all P values were between 0.002 and 0.007). The ratio of cir-
culating neutrophils to lymphocyteswas first similar in treat-
ment groups and remained similar in and between groups
across 24 months. Noteworthy adverse effects were not en-
countered in either treatment group.4
Discussion |Prolonged insulin sensitization (withPioFluMet) is
emerging as a first approach with antiaging effects and in-
cludes a slow marked reversible increment of LTL in adoles-
cent girls with HIAE.
A comparablymarked LTL incrementwas reported on ini-
tiatingthetreatmentwithsitagliptin inolderChineseadultswith
type 2 diabetesmellitus.5 In that study, telomere lengthswere
in the subnormal range at the start of treatment and increased
to a healthy range within 2 months in parallel with improved
glucose level control. In our young studypopulation, telomere
lengthswere in the healthy range at the start of treatment and
increased to the supranormal range after a longer intervention
(12 to 18months) in the absence of diabetesmellitus.
Future studies should disclose whether other insulin-
sensitizing interventions (suchas flutamidebeing replacedby
spironolactone)canalsoelicit telomere lengthening in lateado-
lescence and whether telomerase activity is up-regulated,
either indirectly by a less adipose andmore insulin-sensitive
stateordirectly by components, suchaspioglitazone, that can
up-regulate the transcription of telomerase reverse
transcriptase.6Nevertheless,wemaybe closer tounderstand-
ing why some insulin-sensitive women stay forever young.
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A Living Systematic Review of NebulizedHypertonic
Saline for Acute Bronchiolitis in Infants
Grewal and Klassen1 in JAMA Pediatrics note the frustrations
in interpretingevidenceaboutbronchiolitis.Evidence is spread
across a prior meta-analysis and other trials. The Grewal and
Klasseneditorial1 encourages livingsystematic reviews thatare
updated as new trials emerge. We use the topic of nebulized
hypertonic saline for bronchiolitis to propose themethodof a
living systematic review.
Methods | In this meta-analysis, we started by including the
same trials in the Cochrane review by Zhang et al.2 We then
searched for newer trials in the Cochrane Central Register of
Controlled Trials and articles inWeb of Science that cited the
Zhang et al study.2 Ourmethods are detailed online at the liv-
ing review (http://openmetaanalysis.github.io/Hypertonic-
Saline-for-Bronchiolitis/).
Results | We identified 11 new trials (4 only available at
http://clinicaltrials.gov).1 The meta-analysis showed that
hypertonic saline significantly reduced the length of stay
(LOS) among hospitalized infants. Heterogeneity was largely
owing to variation in LOS in the control groups of trials.
Benefit was confined to studies with a long LOS; however,
even within this group study, results of recent trials were
negative. Among infants given multiple doses, symptoms
were improved and hospitalization was reduced. Forest
plots, meta-regressions, and risk of bias assessment are
available online. Quality of evidence as assessed by the
GRADEprofiler was low owing to imprecision and other fac-
tors detailed in the GRADEprofiler online.
Discussion | Prior research was comprehensively summarized
by the Cochrane review. The addition of the newer trials at-
tenuated the results of all outcomes. However, all outcomes
were statistically significant owing to reduction in hospital-
ization in the subgroup analysis of infants who receivedmul-
tiple doses of treatment. The reduction in LOS was confined
to older trials with a longer LOS. We rated the quality of evi-
dence lower than the Cochrane review. This is likely owing to
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